Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetics and Antiepileptic Mood Stabilizer Treatment Response in Bipolar Disorder: What do we Know?

1 Sept 2021

Abstract excerpt

Antiepileptic mood stabilizers (AED-MS) are often used to treat bipolar disorder (BD). Similar to other mood disorder medications, AED-MS treatment response varies between patients. Identification of biomarkers associated with treatment response may ultimately help with the delivery of individualized treatment and lead to improved treatment efficacy. Here, we conducted a narrative review of the current knowledge...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder and Treatment
Share to HIV/AIDS drug development and treatment
Share to Pharmacological Effects and Toxicity Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34486896
DOI: 10.2217/pgs-2021-0041

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetics and Antiepileptic Mood Stabilizer Treatment Response in Bipolar Disorder: What do we Know?PMID 34486896Read ↗

Mood-Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome-Wide Association Study.Semantic proximity Read ↗

Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium study.Semantic proximity Read ↗

Pharmacogenomics of Bipolar DisorderSemantic proximity Read ↗

Can the response to mood stabilizers be predicted in bipolar disorder?Semantic proximity Read ↗

Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selectionSemantic proximity Read ↗

Pharmacogenomic aspects of bipolar disorder: An updateSemantic proximity Read ↗

Antipsychotic Use in Bipolar Disorder: Clinical and Genomic Correlates– A Mayo Clinic Bipolar Disorder Biobank StudySemantic proximity Read ↗

Pharmacogenetic and Pharmacogenomic Research in Psychiatry: Current Advances and Clinical Applications.Semantic proximity Read ↗

Recent Trends on the Role of Epigenomics, Metabolomics and Noncoding RNAs in Rationalizing Mood Stabilizing TreatmentSemantic proximity Read ↗

Pharmacogenetic considerations in the treatment of psychiatric disorders.Semantic proximity Read ↗

Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression.Semantic proximity Read ↗

The pharmacogenomics of valproic acid.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.